All studies
Ongoing, recruitingTherapeutic exploratory (Phase II)Interventional
A phase II, national, multicenter, uncontrolled and open trial to evaluate the feasibility and safety of lamparoscopic administration of allogenic mesenchymals stem cell (adMSC) extracted by lipoaspirate from healthy patients, for the treatment of patients with inflammatory bowel strictures associated with Crohn's disease. SM
At a glance
Status
Ongoing, recruiting
Phase
Therapeutic exploratory (Phase II)
Sponsor
Instituto De Investigacion Sanitaria Fundacion Jimenez Diaz
Enrolment target
20
Start
28 Jul 2023
What is this study about?
proportion and type of complications arising from treatment (adverse reactions) Complications during anesthesia, Complications arising from the treatment administration procedure
Who may be eligible?
Age 18 Years to any · Sex: All
Locations (1)
- —Spain
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.